These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31617368)

  • 1. Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines.
    Wang W; Keller MD; Baughman T; Wilson BK
    Appl Spectrosc; 2020 Mar; 74(3):323-333. PubMed ID: 31617368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of twelve portable devices for medicine quality screening.
    Zambrzycki SC; Caillet C; Vickers S; Bouza M; Donndelinger DV; Geben LC; Bernier MC; Newton PN; Fernández FM
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009360. PubMed ID: 34591844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field.
    Wilson BK; Kaur H; Allan EL; Lozama A; Bell D
    Am J Trop Med Hyg; 2017 May; 96(5):1117-1123. PubMed ID: 28219992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of field detection devices for antimalarial quality screening in Lao PDR-A cost-effectiveness analysis.
    Luangasanatip N; Khonputsa P; Caillet C; Vickers S; Zambrzycki S; Fernández FM; Newton PN; Lubell Y
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009539. PubMed ID: 34591842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic techniques combined with chemometrics for fast on-site characterization of suspected illegal antimicrobials.
    Tie Y; Duchateau C; Van de Steene S; Mees C; De Braekeleer K; De Beer T; Adams E; Deconinck E
    Talanta; 2020 Sep; 217():121026. PubMed ID: 32498874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of Substandard and Falsified Formulations from Genuine Pharmaceuticals Using NIR Spectra and Machine Learning.
    Awotunde O; Roseboom N; Cai J; Hayes K; Rajane R; Chen R; Yusuf A; Lieberman M
    Anal Chem; 2022 Sep; 94(37):12586-12594. PubMed ID: 36067409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
    Higgins CR; Kobia B; Ozawa S
    PLoS One; 2023; 18(1):e0268661. PubMed ID: 36652447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the qualitative performances of handheld NIR and Raman spectrophotometers for the detection of falsified pharmaceutical products.
    Ciza PH; Sacre PY; Waffo C; Coïc L; Avohou H; Mbinze JK; Ngono R; Marini RD; Hubert P; Ziemons E
    Talanta; 2019 Sep; 202():469-478. PubMed ID: 31171209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.
    Yoshida N
    Biol Pharm Bull; 2024; 47(5):878-885. PubMed ID: 38692863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection Method of Falsified Medicines by Using a Low-Cost Raman Scattering Spectrometer Combined with Soft Independent Modeling of Class Analogy and Partial Least Squares Discriminant Analysis.
    Sanada T; Yoshida N; Kimura K; Tsuboi H
    Biol Pharm Bull; 2021; 44(5):691-700. PubMed ID: 33952825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the performance of a handheld Raman device for potential use as a screening tool in evaluating medicines quality.
    Hajjou M; Qin Y; Bradby S; Bempong D; Lukulay P
    J Pharm Biomed Anal; 2013 Feb; 74():47-55. PubMed ID: 23245232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative field evaluation of six medicine quality screening devices in Laos.
    Caillet C; Vickers S; Zambrzycki S; Fernández FM; Vidhamaly V; Boutsamay K; Boupha P; Peerawaranun P; Mukaka M; Newton PN
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009674. PubMed ID: 34591852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi.
    Khuluza F; Kigera S; Heide L
    Am J Trop Med Hyg; 2017 May; 96(5):1124-1135. PubMed ID: 28219993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of several strategies for the deployment of a multivariate regression model on several handheld NIR instruments. Application to the quality control of medicines.
    Ciza PH; Sacre PY; Waffo C; Kimbeni TM; Masereel B; Hubert P; Ziemons E; Marini RD
    J Pharm Biomed Anal; 2022 Jun; 215():114755. PubMed ID: 35430411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falsified vardenafil tablets available online.
    Zhu S; Yoshida N; Kimura K; Matsushita R; Tsuboi H
    J Pharm Biomed Anal; 2020 Jan; 177():112872. PubMed ID: 31525574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.
    Mori AT; Meena E; Kaale EA
    BMJ Open; 2018 Jun; 8(6):e021825. PubMed ID: 29950474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current challenges in the detection and analysis of falsified medicines.
    Bakker-'t Hart IME; Ohana D; Venhuis BJ
    J Pharm Biomed Anal; 2021 Apr; 197():113948. PubMed ID: 33582458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.